Shares of Open Orphan Plc (LON: ORPH) today surged 9.9% higher after revealing that it had won a £4million contract with a top-three global pharmaceutical company to carry out a human challenge study for its respiratory syncytial virus (RSV).
Investors were pleased by the fact that the company’s latest contract comes just six weeks after it won a major contract with another top-three pharmaceutical company. This is also the third RSV contract won by the company this year and is evidence of its ability to generate new business from major pharma companies.
Cathal Frie, Open Orphan’s chairman said that the latest contract was “evidence of the high regard hVIVO is held in within the industry and reinforces our position as the world leader in the testing of vaccines and antivirals using human challenge clinical trials”.
Interested in investing after today’s move?
XTB gives investors access to thousands of UK and international stocks,
including fractional shares from just £1.
Explore stocks with XTB →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
Want to invest in the stocks making the news?
Go from following the market to investing in it, with access to thousands
of stocks across major UK and international markets.
See available stocks →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
Own the stocks you’re reading about
Invest in real shares across the UK, US and other major global markets
through XTB, all from one investment account.
Explore XTB shares →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
You don’t need to buy a whole share
Fractional shares let you invest from just £1, giving you more control
over how much you put into individual companies.
Explore fractional shares →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
Want to see how XTB works first?
Explore the platform with an XTB demo account before deciding whether
you want to invest with real money.
Try the XTB demo →
Your capital is at risk. The value of your investments may go up or down. Past performance is not a reliable indicator of future performance.
He added: “As a group, we are focused on winning and delivering high-quality, profitable contracts and this is another example of our delivery against that strategy.”
Open Orphan share price
The company’s share price spiked 9.9% higher to trade at 14.95p before retracing some of its gains to trade 5.5% higher at 14.20p.
